Seres Therapeutics Inc (NASDAQ:MCRB)

3.64
Delayed Data
As of 3:59pm ET
 +0.205 / +5.98%
Today’s Change
2.50
Today|||52-Week Range
23.89
-56.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.0021.8M32.1M28.3M
 
 
 
 
Depreciation And Amortization728.0K4.2M7.3M7.9M
 
 
 
 
 
 
Operating ExpensesGross Income-728.0K------
 
 
General Expenses54.1M110.4M116.2M120.7M
 
 
 
 
 
Research And Development38.1M82.0M89.5M96.0M
 
 
 
 
 
Total Operating Expenses54.9M114.6M123.5M128.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-54.9M-92.8M-91.4M-100.3M
 
 
 
 
 
Extraordinary Charge-147.0K0.000.000.00
 
 
Interest Expense On Debt415.0K0.000.000.00
 
 
Other Expenses0.00-969.0K425.0K170.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-54.8M-91.6M-89.4M-98.9M
 
 
 
 
 
Net Income-54.8M-91.6M-89.4M-98.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.5M39.8M40.4M40.7M
 
 
 
 
 
Shares To Calculate EPS Diluted23.5M39.8M40.4M40.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.33-$2.30-$2.21-$2.43
 
 
 
 
 
EPS Diluted-$2.33-$2.30-$2.21-$2.43